In contrast, apoptosis was not induced when non-leukemic B cells, T cells, or NK cells were cultured with BGB324 [60] and AXL-negative patient samples and healthy bone marrow mononuclear cells were similarly resistant to BGB324 [9], underlining the potential for selective targeting of AXL as a therapeutic strategy in leukemia. Here, AXL is linked to leukemia.